- Home
- ORIC vs HEPS Comparison
ORIC vs HEPS Comparison
Compare ORIC & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- HEPS
- Stock Information
- Founded
- ORIC 2014
- HEPS 2000
- Country
- ORIC United States
- HEPS Turkey
- Employees
- ORIC N/A
- HEPS N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- HEPS Catalog/Specialty Distribution
- Sector
- ORIC Health Care
- HEPS Consumer Discretionary
- Exchange
- ORIC Nasdaq
- HEPS Nasdaq
- Market Cap
- ORIC 1.1B
- HEPS 870.4M
- IPO Year
- ORIC 2020
- HEPS 2021
- Fundamental
- Price
- ORIC $12.96
- HEPS $2.62
- Analyst Decision
- ORIC Strong Buy
- HEPS
- Analyst Count
- ORIC 8
- HEPS 0
- Target Price
- ORIC $16.57
- HEPS N/A
- AVG Volume (30 Days)
- ORIC 1.5M
- HEPS 209.4K
- Earning Date
- ORIC 11-06-2025
- HEPS 12-09-2025
- Dividend Yield
- ORIC N/A
- HEPS N/A
- EPS Growth
- ORIC N/A
- HEPS N/A
- EPS
- ORIC N/A
- HEPS N/A
- Revenue
- ORIC N/A
- HEPS $1,477,672,859.00
- Revenue This Year
- ORIC N/A
- HEPS $37.91
- Revenue Next Year
- ORIC N/A
- HEPS $28.48
- P/E Ratio
- ORIC N/A
- HEPS N/A
- Revenue Growth
- ORIC N/A
- HEPS 49.45
- 52 Week Low
- ORIC $3.90
- HEPS $2.41
- 52 Week High
- ORIC $14.93
- HEPS $3.85
- Technical
- Relative Strength Index (RSI)
- ORIC 53.61
- HEPS 42.95
- Support Level
- ORIC $11.71
- HEPS $2.55
- Resistance Level
- ORIC $13.80
- HEPS $2.69
- Average True Range (ATR)
- ORIC 0.69
- HEPS 0.06
- MACD
- ORIC -0.11
- HEPS 0.01
- Stochastic Oscillator
- ORIC 50.63
- HEPS 43.75
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.